✦ LIBER ✦

Immediate versus delayed thoracic radiotherapy (TRT) in patients with unresectable, locally advanced non-small cell lung cancer (NSCLC) and minimal symptoms: Results of an MRC/BTS randomised trial

✍ Scribed by Girling, D.J; Falk, S; White, R; Hopwood, P; Girling, D.J; Falk, S.J; White, R.J; Hopwood, P; Sambrook, R.J; Harvey, A; Qian, W; Stephans, R.J

Book ID: 118570100
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 109 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80555-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immediate thoracic radiotherapy may not

Immediate thoracic radiotherapy may not improve symptom control over delayed radiotherapy in people with unresectable non-small cell lung cancer and minimal symptoms: Abstracted from: Falk S, Girling D, White R et al. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial. British Medical Journal 2002; 325: 465–72.

✍ George A Plataniotis 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB

P-246 Paclitaxel-carboplatine (PC) conso

P-246 Paclitaxel-carboplatine (PC) consolidation chemotherapy versus observation after weekly PC and concurrent thoracic radiation (TRT) for patients with locally advanced non small cell lung cancer (LA-NSCLC): results of the B001-phase II GERCOR-study

✍ Colin, P.; Ganem, G.; Duhamel, J.P.; Oster, J.P.; Benichou, M.; Guichard, F.; Ka 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Amifostine as mucosal protectant in pati

Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT): results of the radiation therapy oncology group (RTOG) 98–01 study

✍ M Werner-Wasik; C Scott; B Movsas; C Langer; L Sarna; N Nicolaou; R Komaki; M Ma 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 20 KB

P-603 Symptom response following high do

P-603 Symptom response following high dose (HD) palliative radiotherapy (RT) plus concurrent weekly vinorelbine (V) and cis-platinum (C) in patients with locally advanced and metastatic non-small cell lung cancer (NSCLC): Results of a phase-I study

✍ Wirth, Andrew; Michael, Michael; Ball, David; MacManus, Michael; Rischin, Danny; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB